Jane Street’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
Other funds holding PLX
Jane Street's PLX Position: Q3 2026 in Review
Jane Street sold out of Protalix BioTherapeutics (PLX) in Q3 2026, closing a stake of 18,020 shares — an estimated $44.8K sold.
Jane Street first reported a position in PLX in Q2 2013 and held it in 48 quarters. The position peaked at $753K in Q1 2025. 107 funds tracked by Wall St. Rank hold PLX as of Q3 2026.
- Jane Street reported no remaining Protalix BioTherapeutics position as of Q3 2026 after selling out during the quarter.
- Jane Street sold 18,020 Protalix BioTherapeutics shares in Q3 2026, an estimated $44.8K.
- Jane Street first reported a position in Protalix BioTherapeutics in Q2 2013 and held it in 48 quarters.
- Jane Street's Protalix BioTherapeutics position peaked at $753K in Q1 2025.
- 107 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.